Diamyd Medical AB (publ) (DMYD-B.ST)
SEK 16.12
(2.54%)
SEK 16.12
(2.54%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 130 Thousand | 546 Thousand | 454 Thousand | 253 Thousand | 341 Thousand | 1.56 Million |
| Cost of Revenue | 3.71 Million | 3.63 Million | 4.4 Million | 2.5 Million | 4.48 Million | 1.69 Million |
| Gross Profit | -3.58 Million | -3.08 Million | -3.94 Million | -2.24 Million | -4.14 Million | -125 Thousand |
| Operating Expenses | 142.98 Million | 112.75 Million | 110.98 Million | 83.63 Million | -13.88 Million | 36.44 Million |
| Selling, General and Administrative Expenses | 44.78 Million | 39.69 Million | 11.66 Million | 9.45 Million | 6.85 Million | 6.01 Million |
| Research and Development Expenses | 96.48 Million | 69.9 Million | 75.56 Million | 56.86 Million | 13.81 Million | 22.35 Million |
| Other Expenses | 1.71 Million | 42.84 Million | 23.75 Million | 17.31 Million | -34.55 Million | 8.06 Million |
| Cost and Expenses | 146.69 Million | 116.39 Million | 115.39 Million | 86.13 Million | -9.39 Million | 38.13 Million |
| Operating Income | -146.56 Million | -120.8 Million | -118.17 Million | -85.88 Million | 9.73 Million | -36.56 Million |
| Interest Expense | 2.14 Million | 3000.00 | 253 Thousand | 453 Thousand | 530 Thousand | 121 Thousand |
| Income Tax Expense | - | 4.73 Million | -14.65 Million | -143.96 Million | 530 Thousand | 121 Thousand |
| Earnings before Tax | -151.85 Million | -116.07 Million | -103.51 Million | 60.04 Million | 9.7 Million | -36.61 Million |
| Net Income | -151.85 Million | -116.07 Million | -88.85 Million | 204 Million | 9.7 Million | -36.73 Million |
| Earnings Per Share Basic | -1.60 | -1.48 | -1.13 | 2.78 | 0.14 | -0.55 |
| Earnings Per Share Diluted | -1.60 | -1.48 | -1.13 | 2.78 | 0.14 | -0.55 |
| Weighted Average Shares Outstanding | 94.71 Million | 78.28 Million | 78.38 Million | 73.3 Million | 70.84 Million | 66.95 Million |
| Weighted Average Shares Outstanding (Diluted) | 94.71 Million | 78.28 Million | 78.38 Million | 73.3 Million | 70.84 Million | 66.95 Million |
| Gross Margin | -27.54 | -5.66 | -8.70 | -8.89 | -12.16 | -0.08 |
| EBIT Margin | -1083.47 | -203.67 | -232.45 | -328.59 | 30.46 | -23.18 |
| Profit Margin | -1168.08 | -212.59 | -195.72 | 806.35 | 28.47 | -23.43 |
| EBITDA | -140.85 Million | -110.97 Million | -95.89 Million | -85.29 Million | -33.28 Million | -36.34 Million |
| Earnings Before Tax Margin | -1127.44 | -221.26 | -260.30 | -339.45 | 28.56 | -23.32 |
| Breakdown | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY |
|---|---|---|---|---|---|---|
| Revenue | 18 Thousand | 52 Thousand | 26 Thousand | 34 Thousand | 74 Thousand | 546 Thousand |
| Cost of Revenue | 829 Thousand | 14.05 Million | 12.87 Million | 1.14 Million | 1.02 Million | 3.63 Million |
| Gross Profit | -811 Thousand | -14 Million | -12.84 Million | -1.1 Million | -947 Thousand | -3.08 Million |
| Operating Expenses | 41.47 Million | 27.3 Million | 16.97 Million | 29.84 Million | 36.42 Million | 112.75 Million |
| Selling, General and Administrative Expenses | 10.83 Million | 11.66 Million | 10.72 Million | 11.56 Million | 10.12 Million | - |
| Research and Development Expenses | 34.51 Million | 27.3 Million | 16.97 Million | 17.68 Million | 19.83 Million | - |
| Other Expenses | -3.88 Million | - | - | - | - | - |
| Cost and Expenses | 42.3 Million | 41.36 Million | 29.85 Million | 30.98 Million | 37.44 Million | 116.39 Million |
| Operating Income | -42.28 Million | -41.3 Million | -29.82 Million | -32.02 Million | -38.73 Million | -120.8 Million |
| Interest Expense | 57 Thousand | - | 491 Thousand | 1.59 Million | - | 3000.00 |
| Income Tax Expense | -15.98 Million | 1.25 Million | 1.22 Million | 833 Thousand | 1.21 Million | 4.73 Million |
| Earnings before Tax | -49.74 Million | -38.81 Million | -28.03 Million | -32.78 Million | -37.51 Million | -116.07 Million |
| Net Income | -49.74 Million | -40.07 Million | -29.25 Million | -32.78 Million | -37.51 Million | -116.07 Million |
| Earnings Per Share Basic | -0.50 | -0.41 | -0.31 | -0.37 | -0.46 | - |
| Earnings Per Share Diluted | -0.50 | -0.41 | -0.31 | -0.37 | -0.46 | - |
| Weighted Average Shares Outstanding | 99.72 Million | 96.6 Million | 94.94 Million | 87.49 Million | 82.31 Million | 78.28 Million |
| Weighted Average Shares Outstanding (Diluted) | 99.72 Million | 96.6 Million | 94.94 Million | 87.49 Million | 82.31 Million | 78.28 Million |
| Gross Margin | -45.06 | -269.35 | -494.19 | -32.62 | -12.80 | -5.66 |
| EBIT Margin | -2504.17 | -766.44 | -1095.15 | -879.06 | -489.14 | - |
| Profit Margin | -2763.33 | -770.67 | -1125.04 | -964.21 | -506.93 | -212.59 |
| EBITDA | -45.07 Million | -39.85 Million | -28.47 Million | -29.88 Million | -36.19 Million | - |
| Earnings Before Tax Margin | -2349.11 | -794.38 | -1147.19 | -941.88 | -523.42 | -221.26 |
CNQQF
SPELS
RATHF
CETI
601200
1918